Molecular genetic advances in sleep research and their relevance to sleep medicine

Sleep

Volumn 28, Issue 3, 2005, Pages 357-367

  Wisor, Jonathan P ^a   Kilduff, Thomas S ^a  

^a SRI INTERNATIONAL   (United States)

Author keywords

Circadian genes; Gamma hydroxybutyrate; Gene expression; Hypnotics; Hypocretin; Modafinil; Molecular genetics; Mutant mice; Sleep deprivation

Indexed keywords

4 HYDROXYBUTYRIC ACID; ADENOSINE; BENZODIAZEPINE DERIVATIVE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYPNOTIC SEDATIVE AGENT; INTERFERON RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; MODAFINIL; NITRIC OXIDE; PROSTAGLANDIN D2; TUMOR NECROSIS FACTOR;

CONTROLLED STUDY; CORRELATION ANALYSIS; GENETIC ANALYSIS; GENETIC ENGINEERING; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR GENETICS; NEUROBIOLOGY; NEUROCHEMISTRY; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; REVIEW; SLEEP; STRAIN IDENTIFICATION;

ANIMALS; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; CIRCADIAN RHYTHM; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DISORDERS OF EXCESSIVE SOMNOLENCE; ELECTROENCEPHALOGRAPHY; GENE EXPRESSION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ION CHANNELS; MICE; MOLECULAR BIOLOGY; NEUROPEPTIDES; RESEARCH; SEROTONIN; SIGNAL TRANSDUCTION; SLEEP; SODIUM OXYBATE; WAKEFULNESS;

EID: 14644395607     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (154)

1. Kilduff TS, Mignot E. Molecular and genetic aspects of sleep. In: Turek, FW, Zee, PC, eds. Regulation of Sleep and Circadian Rhythms. New York: Marcel Dekker; 1999:343-67.
2. Franken P, Tafti M. Genetics of sleep and sleep disorders. Front Biosci 2003;8:381-97.
3. Tobler I, Gaus SE, Deboer T, et al. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 1996;380:639-42.
4. Tafti M, Franken P. Invited Review: Genetic dissection of sleep. J Appl Physiol 2002;92:1339-47.
5. Shaw PJ, Franken P. Perchance to dream: solving the mystery of sleep through genetic analysis. J Neurobiol 2003;54:179-202.
6. de Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998;95:322-7.
7. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:573-85.
8. Peyron C, Tighe DK, van den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998;18:9996-10015.
9. Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999;98:437-51.
10. Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999;98:365-76.
11. Hungs M, Fan J, Lin L, Lin X, Maki RA, Mignot E. Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Genome Res 2001;11:531-9.
12. Levchenko A, Montplaisir JY, Dube MP, et al. The 14q restless legs syndrome locus in the French Canadian population. Ann Neurol 2004;55:887-91.
13. Toh KL, Jones CR, He Y, et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 2001;291:1040-3.
14. Ebisawa T, Uchiyama M, Kajimura N, et al. Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. EMBO Rep 2001;2:342-6.
15. Amiel J, Laudier B, Attie-Bitach T, et al. Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet 2003;33:459-61.
16. Kisanuki YY, Chemelli RM, Tokita S, Willie JT, Sinton CM, Yanagisawa M. Behavioral and polysomnographic characterization of orexin-1 receptor and orexin-2 receptor double knockout mice. Sleep 2001;24:A22.
17. Mieda M, Willie JT, Hara J, Sinton CM, Sakurai T, Yanagisawa M. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci U S A 2004;101:4649-54.
18. Willie JT, Chemelli RM, Sinton CM, et al. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron 2003;38:715-30.
19. Hara J, Beuckmann CT, Nambu T, et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001;30:345-54.
20. Beuckmann CT, Sinton CM, Williams SC, et al. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci 2004;24:4469-77.
21. Mochizuki T, Crocker A, McCormack S, Yanagisawa M, Sakurai T, Scammell TE. Behavioral state instability in orexin knock-out mice. J Neurosci 2004;24:6291-300.
22. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-7.
23. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:469-74.
24. Zhu Y, Miwa Y, Yamanaka A, et al. Orexin receptor type-1 couples exclusively to pertussis toxin-insensitive G-proteins, while orexin receptor type-2 couples to both pertussis toxin-sensitive and -insensitive G-proteins. J Pharmacol Sci 2003;92:259-66.
25. Kisanuki YY, Chemelli RM, Sinton CM, et al. The role of orexin receptor type-1 (OX1R) in the regulation of sleep. Sleep 2000;23:A91.
26. Li Y, Gao XB, Sakurai T, van den Pol AN. Hypocretin/orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system. Neuron 2002;36:1169-81.
27. Yamanaka A, Beuckmann CT, Willie JT, et al. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003;38:701-13.
28. Muraki Y, Yamanaka A, Tsujino N, Kilduff TS, Goto K, Sakurai T. Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor. J Neurosci 2004;24:7159-66.
29. Acuna-Goycolea C, Li Y, Van Den Pol AN. Group III metabotropic glutamate receptors maintain tonic inhibition of excitatory synaptic input to hypocretin/orexin neurons. J Neurosci 2004;24:3013-22.
30. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40.
31. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002;59:1553-62.
32. John J, Wu MF, Siegel JM. Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs. Sleep Res Online 2000;3:23-8.
33. Fujiki N, Yoshida Y, Ripley B, Mignot E, Nishino S. Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog. Sleep 2003;26:953-9.
34. Soffin EM, Gill CH, Brough SJ, Jerman JC, Davies CH. Pharmacological characterisation of the orexin receptor subtype mediating postsynaptic excitation in the rat dorsal raphe nucleus. Neuropharmacology 2004;46:1168-76.
35. Hirose M, Egashira S, Goto Y, et al. N-acyl 6,7-dimethoxy-1,2,3,4- tetrahydroisoquinoline: the first orexin-2 receptor selective non-peptidic antagonist. Bioorg Med Chem Lett 2003;13:4497-9.
36. Bourgin P, Huitron-Resendiz S, Spier AD, et al. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 2000;20:7760-5.
37. Xi M, Morales FR, Chase MH. Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat. Brain Res 2001;901:259-64.
38. Espana RA, Baldo BA, Kelley AE, Berridge CW. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 2001;106:699-715.
39. Thakkar MM, Ramesh V, Strecker RE, McCarley RW. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats. Arch Ital Biol 2001;139:313-28.
40. Methippara MM, Alam MN, Szymusiak R, McGinty D. Effects of lateral preoptic area application of orexin-A on sleep-wakefulness. Neuroreport 2000;11:3423-6.
41. Bastuji H, Jouvet M. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuropsychopharmacol Biol Psychiatry 1988;12:695-700.
42. Saper CB, Scammell TE. Modafinil: a drug in search of a mechanism. Sleep 2004;27:11-2.
43. Shelton J, Nishino S, Vaught J, Dement WC, Mignot E. Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs. Sleep 1995;18:817-26.
44. Scammell TE, Estabrooke IV, McCarthy MT, et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000;20:8620-8.
45. Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001;21:1787-94.
46. Stone EA, Cotecchia S, Lin Y, Quartermain D. Role of brain alpha 1B-adrenoceptors in modafinil-induced behavioral activity. Synapse 2002;46:269-70.
47. Auclair A, Cotecchia S, Glowinski J, Tassin JP. D-amphetamine fails to increase extracellular dopamine levels in mice lacking alpha 1b-adrenergic receptors: relationship between functional and non-functional dopamine release. J Neurosci 2002;22:9150-4.
48. Drouin C, Darracq L, Trovero F, et al. Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J Neurosci 2002;22:2873-84.
49. Dauvilliers Y, Neidhart E, Billiard M, Tafti M. Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil. Pharmacogenomics J 2002;2:65-8.
50. Hendricks JC, Sehgal A. Why a fly? Using Drosophila to understand the genetics of circadian rhythms and sleep. Sleep 2004;27:334-42.
51. Hendricks JC, Kirk D, Panckeri K, Miller MS, Pack AI. Modafinil maintains waking in the fruit fly Drosophila melanogaster. Sleep 2003;26:139-46.
52. Parmentier R, Ohtsu H, Djebbara-Hannas Z, Valatx JL, Watanabe T, Lin JS. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 2002;22:7695-711.
53. Bayer L, Eggermann E, Serafin M, et al. Orexins (hypocretins) directly excite tuberomammillary neurons. Eur J Neurosci 2001;14:1571-5.
54. Eriksson KS, Sergeeva O, Brown RE, Haas HL. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 2001;21:9273-9.
55. Huang ZL, Qu WM, Li WD, et al. Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci U S A 2001;98:9965-70.
56. Wisor JP, Wurts SW, Hall FS, et al. Altered rapid eye movement sleep timing in serotonin transporter knockout mice. Neuroreport 2003;14:233-8.
57. Boutrel B, Franc B, Hen R, Hamon M, Adrien J. Key role of 5-HT1B receptors in the regulation of paradoxical sleep as evidenced in 5-HT1B knock-out mice. J Neurosci 1999;19:3204-12.
58. Lena C, Popa D, Grailhe R, Escourrou P, Changeux JP, Adrien J. Beta2-containing nicotinic receptors contribute to the organization of sleep and regulate putative micro-arousals in mice. J Neurosci 2004;24:5711-8.
59. Stenberg D, Litonius E, Halldner L, Johansson B, Fredholm BB, Porkka-Heiskanen T. Sleep and its homeostatic regulation in mice lacking the adenosine A1 receptor. J Sleep Res 2003;12:283-90.
60. Roth T, Hajak G, Ustun TB. Consensus for the pharmacological management of insomnia in the new millennium. Int J Clin Pract 2001;55:42-52.
61. Ziegler G, Ludwig L, Klotz U. Effect of midazolam on sleep. Br J Clin Pharmacol 1983;16:81S-86S.
62. Achermann P, Borbély AA. Dynamics of EEG slow wave activity during physiological sleep and after administration of benzodiazepine hypnotics. Hum Neurobiol 1987;6:203-10.
63. Kopp C, Rudolph U, Low K, Tobler I. Modulation of rhythmic brain activity by diazepam: GABA(A) receptor subtype and state specificity. Proc Natl Acad Sci U S A 2004;101:3674-9.
64. Wisor JP, DeLorey TM, Homanics GE, Edgar DM. Sleep states and sleep electroencephalographic spectral power in mice lacking the beta 3 subunit of the GABA(A) receptor. Brain Res 2002;955:221-8.
65. Tobler I, Kopp C, Deboer T, Rudolph U. Diazepam-induced changes in sleep: role of the alpha 1 GABA(A) receptor subtype. Proc Natl Acad Sci USA 2001;98:6464-9.
66. Kopp C, Rudolph U, Keist R, Tobler I. Diazepam-induced changes on sleep and the EEG spectrum in mice: role of the alpha3-GABA(A) receptor subtype. Eur J Neurosci 2003;17:2226-30.
67. Laposky AD, Homanics GE, Basile A, Mendelson WB. Deletion of the GABAA receptor beta3 subunit eliminates the hypnotic actions of oleamide in mice. Neuroreport 2001;12:4143-4147.
68. Scharf MB. Pharmacology of classic and novel hypnotic drugs: from molecular pharmacology to therapeutics. In: Langer, SZ, Mendlewicz, J, Racagni, C, eds. Target Receptors for Anxiolytics and Hypnotics. Basel: Karger, 1992.
69. Van Cauter E, Plat L, Scharf MB, et al. Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young men. J Clin Invest 1997;100:745-53.
70. Wong CG, Gibson KM, Snead OC, 3rd. From the street to the brain: neurobiology of the recreational drug gamma-hydroxybutyric acid. Trends Pharmacol Sci 2004;25:29-34.
71. Xie X, Smart TG. Gamma-hydroxybutyrate hyperpolarizes hippocampal neurones by activating GABAB receptors. Eur J Pharmacol 1992;212:291-4.
72. Andriamampandry C, Taleb O, Viry S, et al. Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator gamma-hydroxybutyrate (GHB). Faseb J 2003;17:1691-3.
73. Kaupmann K, Cryan JF, Wellendorph P, et al. Specific gamma- hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice. Eur J Neurosci 2003;18:2722-30.
74. Queva C, Bremner-Danielsen M, Edlund A, et al. Effects of GABA agonists on body temperature regulation in GABA(B(1))-/- mice. Br J Pharmacol 2003;140:315-22.
75. Beuckmann CT, Sinton CM, Miyamoto N, Ino M, Yanagisawa M. N-type calcium channel alpha1B subunit (Cav2.2) knock-out mice display hyperactivity and vigilance state differences. J Neurosci 2003;23:6793-7.
76. Espinosa F, Marks G, Heintz N, Joho RH. Increased motor drive and sleep loss in mice lacking Kv3-type potassium channels. Genes Brain Behav 2004;3:90-100.
77. Vyazovskiy VV, Deboer T, Rudy B, Lau D, Borbely AA, Tobler I. Sleep EEG in mice that are deficient in the potassium channel subunit K.v.3.2. Brain Res 2002;947:204-11.
78. Borbély AA, Tobler I. Endogenous sleep-promoting substances and sleep regulation. Physiol Rev 1989;69:605-670.
79. Krueger JM, Obal FJ, Fang J, Kubota T, Taishi P. The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci 2001;933:211-21.
80. Porkka-Heiskanen T. Adenosine in sleep and wakefulness. Ann Med 1999;31:125-9.
81. Fang J, Wang Y, Krueger JM. Mice lacking the TNF 55 kDa receptor fail to sleep more after TNFalpha treatment. J Neurosci 1997;17:5949-55.
82. Deboer T, Fontana A, Tobler I. Tumor necrosis factor (TNF) ligand and TNF receptor deficiency affects sleep and the sleep EEG. J Neurophysiol 2002;88:839-46.
83. Dijk D-J, Czeisler CA. Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves, and sleep spindle activity in humans. J Neurosci 1995;15:3526-38.
84. Borbely AA, Achermann P. Sleep homeostasis and models of sleep regulation. In: Kryger, MH, Roth, T, Dement, WC, eds. Principles and Practice of Sleep Medicine. Philadelphia: W.B. Saunders, 2000: 377-90.
85. King DP, Takahashi JS. Molecular genetics of circadian rhythms in mammals. Annu Rev Neurosci 2000;23:713-42.
86. Reppert SM, Weaver DR. Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 2001;63:647-76.
87. Van Gelder RN. Recent insights into mammalian circadian rhythms. Sleep 2004;27:166-71.
88. Jones CR, Campbell SS, Zone SE, et al. Familial advanced sleep-phase syndrome: a short-period circadian rhythm variant in humans. Nat Med 1999;5:1062-5.
89. Wisor JP. Disorders of the circadian clock: Etiology and possible therapeutic targets. Curr Drug Targets CNS Neurol Disord 2002;1:555-66.
90. King DP, Zhao Y, Sangoram AM, et al. Positional cloning of the mouse circadian clock gene. Cell 1997;89:641-653.
91. Abe M, Herzog ED, Yamazaki S, et al. Circadian rhythms in isolated brain regions. J Neurosci 2002;22:350-6.
92. Naylor E, Bergmann BM, Krauski K, et al. The circadian clock mutation alters sleep homeostasis in the mouse. J Neurosci 2000;20:8138-43.
93. Wisor JP, O'Hara BF, Terao A, et al. A role for cryptochromes in sleep regulation. BMC Neurosci 2002;3:20.
94. Kopp C, Albrecht U, Zheng B, Tobler I. Homeostatic sleep regulation is preserved in mPerl and mPer2 mutant mice. Eur J Neurosci 2002;16:1099-106.
95. Shiromani PJ, Xu M, Winston EM, Shiromani SN, Gerashchenko D, Weaver DR. Sleep rhythmicity and homeostasis in mice with targeted disruption of mPeriod genes. Am J Physiol Regul Integr Comp Physiol 2004;287:R47-R57.
96. Ward CP, Shaw PJ, Dauphin LJ, McKenna JT, McCarley RW, Strecker RE. Comparison of sleep homeostasis in BMAL1 KO mice and Drosophila cyc01 and cyc02 mutants. Sleep 2004;27:A378.
97. Franken P, Lopez-Molina L, Marcacci L, Schibler U, Tafti M. The transcription factor DBP affects circadian sleep consolidation and rhythmic EEG activity. J Neurosci 2000;20:617-25.
98. Shaw PJ, Cirelli C, Greenspan RJ, Tononi G. Correlates of sleep and waking in Drosophila melanogaster. Science 2000;287:1834-7.
99. Hendricks JC, Finn SM, Panckeri KA, et al. Rest in Drosophila is a sleep-like state. Neuron 2000;25:129-38.
100. Shaw PJ, Tononi G, Greenspan RJ, Robinson DF. Stress response genes protect against lethal effects of sleep deprivation in Drosophila. Nature 2002;417:287-91.
101. Hendricks JC, Williams JA, Panckeri K, et al. A non-circadian role for cAMP signaling and CREB activity in Drosophila rest homeostasis. Nat Neurosci 2001;4:1108-15.
102. Dudley CA, Erbel-Sieler C, Estill SJ, et al. Altered patterns of sleep and behavioral adaptability in NPAS2-deficient mice. Science 2003;301:379-83.
103. Edgar DM. Functional role of the suprachiasmatic nuclei in the regulation of sleep and wakefulness. In: Guilleminault, C, ed. Fatal Familial Insomnia: Inherited Prion Diseases, Sleep and the Thalamus. New York: Raven Press, Ltd.; 1994:203-13.
104. Tobler I, Borbély AA, Groos G. The effect of sleep deprivation on sleep in rats with suprachiasmatic lesions. Neurosci Lett 1983;42:49-54.
105. Mistlberger RE, Bergmann BM, Waldenar W, Rechtschaffen A. Recovery sleep following sleep deprivation in intact and suprachiasmatic nuclei-lesioned rats. Sleep 1983;6:217-33.
106. Mendelson WB, Bergmann BM, Tung A. Baseline and post-deprivation recovery sleep in SCN-lesioned rats. Brain Res 2003;980:185-90.
107. Baker FC, Angara CA, Stewart DR, Szymusiak R, McGinty D. Sleep and thermoregulation in rats with suprachiasmatic nuclei lesions. Sleep 2004;27:28.
108. Easton A, Meerlo P, Bergmann B, Turek FW. The suprachiasmatic nucleus regulates sleep timing and amount in mice. Sleep 2004;27:1307-18.
109. Ramm P, Smith CT. Rates of cerebral protein synthesis are linked to slow wave sleep in the rat. Physiol Behav 1990;48:749-53.
110. Nakanishi H, Sun Y, Nakamura RK, et al. Positive correlations between cerebral protein synthesis rates and deep sleep in Macaca mulatta. Eur J Neurosci 1997;9:271-9.
111. Kubin L, Czyzyk MF, Gozal D. Gene and protein expression and regulation in the central nervous system. In: Carley, DW, Radulovacki, M, eds. Sleep Related Breathing Disorders. New York: Marcel Dekker; 2002:109-79.
112. Ding J, Gip PT, Franken P, Lomas L, O'Hara BF. A proteomic analysis in brain following sleep deprivation suggests a generalized decrease in abundance for many proteins. Sleep 2004;27:A391.
113. Vazquez J, Xu M, Sullivan MP, Greco MA. Alterations in cortical protein profiles across spontaneous sleep-wakefulness. Sleep 2004;27:A27.
114. Cirelli C, Tononi G. Locus ceruleus control of state-dependent gene expression. J Neurosci 2004;24:5410-9.
115. Terao A, Steininger TL, Hyder K, et al. Differential increase in the expression of heat shock protein family members during sleep deprivation and during sleep. Neuroscience 2003;116:187-200.
116. Cirelli C, Tononi G. Gene expression in the brain across the sleep-waking cycle. Brain Res 2000;885:303-21.
117. Cirelli C, Tononi G. Differences in gene expression during sleep and wakefulness. Ann Med 1999;31:117-24.
118. Graves LA, Heller EA, Pack AI, Abel T. Sleep deprivation selectively impairs memory consolidation for contextual fear conditioning. Learn Mem 2003;10:168-76.
119. Drummond SP, Brown GG, Gillin JC, Stricker JL, Wong EC, Buxton RB. Altered brain response to verbal learning following sleep deprivation. Nature 2000;403:655-7.
120. Huber R, Felice Ghilardi M, Massimini M, Tononi G. Local sleep and learning. Nature 2004;430:78-81.
121. Walker MP, Brakefield T, Hobson JA, Stickgold R. Dissociable stages of human memory consolidation and reconsolidation. Nature 2003;425:616-20.
122. Aston-Jones G, Bloom FE. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1981;1:876-86.
123. Cirelli C, Gutierrez CM, Tononi G. Extensive and divergent effects of sleep and wakefulness on brain gene expression. Neuron 2004;41:35-43.
124. Scammell TE, Arrigoni E, Thompson MA, Ronan PJ, Saper CB, Greene RW. Focal deletion of the adenosine A1 receptor in adult mice using an adeno-associated viral vector. J Neurosci 2003;23:5762-70.
125. Cohen G, Han ZY, Grailhe R, et al. ?2 nicotinic acetylcholine receptor subunit modulates protective responses to stress: a receptor basis for sleep-disordered breathing after nicotine exposure. Proc Natl Acad Sci U S A 2002;99:13272-7.
126. Huitron-Resendiz S, Sanchez-Alavez M, Gallegos RA, et al. Characterization of the sleep-wake patterns in mice lacking fatty acid amide hydrolase. Sleep 2004;27:857-865.
127. Toyota H, Dugovic C, Koehl M, et al. Behavioral characterization of mice lacking histamine H(3) receptors. Mol Pharmacol 2002;62:389-97.
128. Hunsley MS, Palmiter RD. Altered sleep latency and arousal regulation in mice lacking norepinephrine. Pharmacol Biochem Behav 2004;78:765-73.
129. Hunsley MS, Palmiter RD. Norepinephrine-deficient mice exhibit normal sleep-wake states but have shorter sleep latency after mild stress and low doses of amphetamine. Sleep 2003;26:521-6.
130. Ouyang M, Hellman K, Abel T, Thomas SA. Adrenergic signaling plays a critical role in the maintenance of waking and in the regulation of REM sleep. J Neurophysiol 2004;92:2071-82.
131. Hunsley M, Palmiter RD. REM sleep and behavioral differences in mice lacking norepinephrine and orexin. Sleep 2004;27:A385.
132. Boutrel B, Monaca C, Hen R, Hamon M, Adrien J. Involvement of 5-HT1A receptors in homeostatic and stress-induced adaptive regulations of paradoxical sleep: Studies in 5-HT1A knockout mice. J Neurosci 2002;22:4686-92.
133. Monaca C, Boutrel B, Hen R, Hamon M, Adrien J. 5-HT 1A/1B receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep: studies in 5-HT 1A and 5-HT 1B knockout mice. Neuropsychopharmacology 2003;28:850-6.
134. Frank MG, Stryker MP, Tecott LH. Sleep and sleep homeostasis in mice lacking the 5-HT2c receptor. Neuropsychopharmacology 2002;27:869-73.
135. Kapfhamer D, Valladares O, Sun Y, et al. Mutations in Rab3a alter circadian period and homeostatic response to sleep loss in the mouse. Nat Genet 2002;32:290-5.
136. Lonart G, Tang X, Simsek-Duran F, Sanford LD. Exploration and sleep in RIM1a knockout (KO) mice following exposure to novel environments. Sleep 2004;27:A384.
137. Anderson MP, Mochizuki MP, Scammell T, Tonegawa S. Region-restricted knockout of T-type calcium channel Cav3.1: Subcortical neuron bursts stabilize NREM sleep. Sleep 2004;27:A383.
138. Urade Y, Eguchi N, Qu WM, et al. Sleep regulation in adenosine A2A receptor-deficient mice. Neurology 2003;61:S94-S96.
139. Fang J, Wang Y, Krueger JM. Effects of interleukin-1 beta on sleep are mediated by the type I receptor. Am J Physiol 1998;274:R655-60.
140. Morrow JD, Opp MR. Sleep-wake behavior and responses of interleukin-6-deficient mice to sleep deprivation. Brain Behav Immun 2005;19:28-39.
141. Morrow JD, Opp MR. Diurnal variation of lipopolysaccharide-induced alterations in sleep and body temperature of interleukin-6-deficient mice. Brain Behav Immun 2005;19:40-51.
142. Toth LA, Opp MR. Cytokine- and microbially induced sleep responses of interleukin-10 deficient mice. Am J Physiol Regul Integr Comp Physiol 2001;280:R1806-14.
143. Bohnet SG, Majde JA, Traynor TR, Krueger JM. Increased expression of hypothalamic orexin mRNA is associated with spontaneous REM sleep suppression in mice deficient in the interferon type I receptor. Sleep 2004;27:A378.
144. Chen L, Majde JA, Krueger JM. Spontaneous sleep in mice with targeted disruptions of neuronal or inducible nitric oxide synthase genes. Brain Res 2003;973:214-22.
145. Pinzar E, Kanaoka Y, Inui T, Eguchi N, Urade Y, Hayaishi O. Prostaglandin D synthase gene is involved in the regulation of non-rapid eye movement sleep. Proc Natl Acad Sci U S A 2000;97:4903-7.
146. Eguchi N, Pinzar E, Inui T, et al. Sleep in gene-knockout and transgenic mice for lipocalin-type prostaglandin D synthase. In: Ishimura, Y, ed. Oxygen and Life: Oxygenases, Oxidases and Lipid Mediators. Amsterdam: Elsevier; 2002:429-33.
147. Mizoguchi A, Eguchi N, Kimura K, et al. Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep. Proc Natl Acad Sci U S A 2001;98:11674-9.
148. Obal F, Jr., Fang J, Taishi P, Kacsoh B, Gardi J, Krueger JM. Deficiency of growth hormone-releasing hormone signaling is associated with sleep alterations in the dwarf rat. J Neurosci 2001;21:2912-8.
149. Obal F, Jr., Alt J, Taishi P, Gardi J, Krueger JM. Sleep in mice with nonfunctional growth hormone-releasing hormone receptors. Am J Physiol Regul Integr Comp Physiol 2003;284:R131-9.
150. Hajdu I, Obal F, Jr., Fang J, Krueger JM, Rollo CD. Sleep of transgenic mice producing excess rat growth hormone. Am J Physiol Regul Integr Comp Physiol 2002;282:R70-6.
151. Zhang J, Obal F, Jr., Fang J, Collins BJ, Krueger JM. Non-rapid eye movement sleep is suppressed in transgenic mice with a deficiency in the somatotropic system. Neurosci Lett 1996;220:97-100.
152. Basheer R, Sherin JE, Saper CB, Morgan JI, McCarley RW, Shiromani PJ. Effects of sleep on wake-induced c-fos expression. J Neurosci 1997;17:9746-50.
153. Shiromani PJ, Basheer R, Thakkar J, Wagner D, Greco MA, Charness ME. Sleep and wakefulness in c-fos and fos B gene knockout mice. Brain Res Mol Brain Res 2000;80:75-87.
154. Graves LA, Hellman K, Veasey S, Blendy JA, Pack AI, Abel T. Genetic evidence for a role of CREB in sustained cortical arousal. J Neurophysiol 2003;90:1152-9.